nach oben

Erschienen in:

11.03.2017 | Original Paper

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

verfasst von: Heidi M. Crane, Mary E. McCaul, Geetanjali Chander, Heidi Hutton, Robin M. Nance, Joseph A. C. Delaney, Joseph O. Merrill, Bryan Lau, Kenneth H. Mayer, Michael J. Mugavero, Matthew Mimiaga, James H. Willig, Greer A. Burkholder, Daniel R. Drozd, Rob J. Fredericksen, Karen Cropsey, Richard D. Moore, Jane M. Simoni, W. Christopher Mathews, Joseph J. Eron, Sonia Napravnik, Katerina Christopoulos, Elvin Geng, Michael S. Saag, Mari M. Kitahata

Erschienen in: AIDS and Behavior | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Hazardous alcohol use is associated with detrimental health outcomes among persons living with HIV (PLWH). We examined the prevalence and factors associated with hazardous alcohol use in the current era using several hazardous drinking definitions and binge drinking defined as ≥5 drinks for men versus ≥4 for women. We included 8567 PLWH from 7 U.S. sites from 2013 to 2015. Current hazardous alcohol use was reported by 27% and 34% reported binge drinking. In adjusted analyses, current and past cocaine/crack (odd ratio [OR] 4.1:3.3–5.1, p < 0.001 and OR 1.3:1.1–1.5, p < 0.001 respectively), marijuana (OR 2.5:2.2–2.9, p < 0.001 and OR 1.4:1.2–1.6, p < 0.001), and cigarette use (OR 1.4:1.2–1.6, p < 0.001 and OR 1.3:1.2–1.5, p < 0.001) were associated with increased hazardous alcohol use. The prevalence of hazardous alcohol use remains high in the current era, particularly among younger men. Routine screening and targeted interventions for hazardous alcohol use, potentially bundled with interventions for other drugs, remain a key aspect of HIV care.

Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–86.CrossRefPubMed

Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Med. 2008;9(4):196–202.CrossRefPubMedPubMedCentral

Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoact Drugs. 2003;35(Suppl 1):153–60.CrossRef

Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep. 2015;12(4):421–36.CrossRefPubMedPubMedCentral

Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016.

Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194–9.CrossRefPubMedPubMedCentral

Chander G, Lau B, Moore R. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefPubMedPubMedCentral

Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16(2):83–8.CrossRefPubMedPubMedCentral

Braithwaite RS, Conigliaro J, Roberts MS, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459–66.CrossRefPubMedPubMedCentral

10.

Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res. 2005;29(5):837–43.CrossRefPubMed

11.

Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107(1):51–9.CrossRefPubMed

12.

Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.CrossRefPubMed

13.

Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450–4.CrossRefPubMed

14.

The Henry J Kasier Foundation. The HIV/AIDS epidemic in the United States. 2017. http://kff.org/hivaids/fact-sheet/the-hivaids-epidemic-in-the-united-states/.

15.

Centers for Disease Control and Prevention. HIV among people aged 50 and over. 2016. https://www.cdc.gov/hiv/group/age/olderamericans/.

16.

Cook RL, Zhu F, Belnap BH, et al. Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol. 2009;169(8):1025–32.CrossRefPubMedPubMedCentral

17.

Lake-Bakaar G, Grimson R. Alcohol abuse and stage of HIV disease in intravenous drug abusers. J R Soc Med. 1996;89(7):389–92.PubMedPubMedCentral

18.

Welch KJ. Correlates of alcohol and/or drug use among HIV-infected individuals. AIDS Patient Care STDS. 2000;14(6):317–23.CrossRefPubMed

19.

Bertholet N, Cheng DM, Samet JH, Quinn E, Saitz R. Alcohol consumption patterns in HIV-infected adults with alcohol problems. Drug Alcohol Depend. 2010;112(1–2):160–3.CrossRefPubMedPubMedCentral

20.

Kitahata MM, Rodriguez BG, Haubrich R, et al. Cohort profile: the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS). Int J Epidemiol. 2008;37(5):948–55.CrossRefPubMedPubMedCentral

21.

Fredericksen RJ, Edwards TC, Merlin JS, et al. Patient and provider priorities for self-reported domains of HIV clinical care. AIDS Care. 2015;27(10):1255–64.CrossRefPubMedPubMedCentral

22.

Kim HN, Nance R, Van Rompaey S, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016;72(4):437–43.CrossRefPubMed

23.

Mimiaga MJ, Biello K, Reisner SL, et al. Latent class profiles of internalizing and externalizing psychosocial health indicators are differentially associated with sexual transmission risk: findings from the CFAR Network of Integrated Clinical Systems (CNICS) cohort study of HIV-infected men engaged in primary care in the United States. Health Psychol. 2015.

24.

Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentral

25.

Bradley KA, McDonell MB, Bush K, Kivlahan DR, Diehr P, Fihn SD. The AUDIT alcohol consumption questions: reliability, validity, and responsiveness to change in older male primary care patients. Alcohol Clin Exp Res. 1998;22(8):1842–9.PubMed

26.

Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–9.CrossRefPubMed

27.

Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26.CrossRefPubMed

28.

WHO Assist Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef

29.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedPubMedCentral

30.

Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.CrossRefPubMed

31.

Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–17.CrossRefPubMed

32.

Gual A, Segura L, Contel M, Heather N, Colom J. AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcoholism. 2002;37(6):591–6.CrossRefPubMed

33.

Lucas N, Windsor TD, Caldwell TM, Rodgers B. Psychological distress in non-drinkers: associations with previous heavy drinking and current social relationships. Alcohol Alcoholism. 2010;45(1):95–102.CrossRefPubMed

34.

Liang W, Chikritzhs T. The association between alcohol exposure and self-reported health status: the effect of separating former and current drinkers. PLoS ONE. 2013;8(2):e55881.CrossRefPubMedPubMedCentral

35.

Crane HM, Nance RM, Merrill JO, et al. Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders. AIDS Care. 2017;29(2):177–84.CrossRefPubMed

36.

Newman JC, Des Jarlais DC, Turner CF, Gribble J, Cooley P, Paone D. The differential effects of face-to-face and computer interview modes. Am J Public Health. 2002;92(2):294–7.CrossRefPubMedPubMedCentral

37.

Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004;99(7):885–96.CrossRefPubMed

38.

Kurth AE, Martin DP, Golden MR, et al. A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis. 2004;31(12):719–26.CrossRefPubMed

39.

Dolezal C, Marhefka SL, Santamaria EK, Leu CS, Brackis-Cott E, Mellins CA. A comparison of audio computer-assisted self-interviews to face-to-face interviews of sexual behavior among perinatally HIV-exposed youth. Arch Sex Behav. 2012;41(2):401–10.CrossRefPubMed

40.

Bryant KJ. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse. 2006;41(10–12):1465–507.CrossRefPubMed

41.

Eigenbrodt ML, Mosley TH Jr, Hutchinson RG, Watson RL, Chambless LE, Szklo M. Alcohol consumption with age: a cross-sectional and longitudinal study of the Atherosclerosis Risk in Communities (ARIC) study, 1987-1995. Am J Epidemiol. 2001;153(11):1102–11.CrossRefPubMed

42.

Merrick EL, Horgan CM, Hodgkin D, et al. Unhealthy drinking patterns in older adults: prevalence and associated characteristics. J Am Geriatr Soc. 2008;56(2):214–23.CrossRefPubMed

43.

Mukamal KJ, Mittleman MA, Longstreth WT Jr, Newman AB, Fried LP, Siscovick DS. Self-reported alcohol consumption and falls in older adults: cross-sectional and longitudinal analyses of the cardiovascular health study. J Am Geriatr Soc. 2004;52(7):1174–9.CrossRefPubMed

44.

Sorock GS, Chen LH, Gonzalgo SR, Baker SP. Alcohol-drinking history and fatal injury in older adults. Alcohol. 2006;40(3):193–9.CrossRefPubMed

45.

Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS (London, England). 2010;24(10):1537–1548.

46.

Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831–7.CrossRefPubMed

47.

Cheng DM, Nunes D, Libman H, et al. Impact of hepatitis C on HIV progression in adults with alcohol problems. Alcohol Clin Exp Res. 2007;31(5):829–36.CrossRefPubMedPubMedCentral

48.

Cooper CL, Cameron DW. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis. 2005;41(Suppl 1):S105–9.CrossRefPubMed

49.

Fishbein DA, Lo Y, Netski D, Thomas DL, Klein RS. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr. 2006;41(4):471–6.CrossRefPubMed

50.

National Institute of Diabetes and Digestive and Kidney Diseases. Chronic Hepatitis C: Current Disease Management. 2010. http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/. Accessed 3 Jan 2010.

51.

Weis N, Lindhardt BO, Kronborg G, et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis. 2006;42(10):1481–7.CrossRefPubMed

52.

Loko MA, Bani-Sadr F, Valantin MA, et al. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther. 2012;17(7):1335–43.CrossRefPubMed

53.

Maier MM, He H, Schafer SD, Ward TT, Zaman A. Hepatitis C treatment eligibility among HIV-hepatitis C virus coinfected patients in Oregon: a population-based sample. AIDS Care. 2014;26(9):1178–85.CrossRefPubMed

54.

Fairley CK, Sze JK, Vodstrcil LA, Chen MY. Computer-assisted self interviewing in sexual health clinics. Sex Transm Dis. 2010;37(11):665–8.CrossRefPubMed

Titel: Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment
verfasst von: Heidi M. Crane
Mary E. McCaul
Geetanjali Chander
Heidi Hutton
Robin M. Nance
Joseph A. C. Delaney
Joseph O. Merrill
Bryan Lau
Kenneth H. Mayer
Michael J. Mugavero
Matthew Mimiaga
James H. Willig
Greer A. Burkholder
Daniel R. Drozd
Rob J. Fredericksen
Karen Cropsey
Richard D. Moore
Jane M. Simoni
W. Christopher Mathews
Joseph J. Eron
Sonia Napravnik
Katerina Christopoulos
Elvin Geng
Michael S. Saag
Mari M. Kitahata
Publikationsdatum: 11.03.2017
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 7/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-017-1740-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2017

Hope Matters: Developing and Validating a Measure of Future Expectations Among Young Women in a High HIV Prevalence Setting in Rural South Africa (HPTN 068)

Effects of Parental Monitoring and Knowledge on Substance Use and HIV Risk Behaviors Among Young Men Who have Sex with Men: Results from Three Studies

Event-Level Associations Among Drinking Motives, Alcohol Consumption, and Condomless Anal Sex in a Sample of Young Men Who Have Sex With Men

Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda

Erratum to: The Role of Structural Barriers in Risky Sexual Behavior, Victimization and Readiness to Change HIV/STI-Related Risk Behavior Among Transgender Women

The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin